Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Deferred Taxes: 2021-2023

Historic Deferred Taxes for ADC Therapeutics (ADCT) over the last 3 years, with Dec 2023 value amounting to $37.1 million.

  • ADC Therapeutics' Deferred Taxes rose 2756.05% to $42.9 million in Q4 2023 from the same period last year, while for Dec 2023 it was $37.1 million, marking a year-over-year increase of 2388.96%. This contributed to the annual value of $37.1 million for FY2023, which is 2388.96% up from last year.
  • As of FY2023, ADC Therapeutics' Deferred Taxes stood at $37.1 million, which was up 2,388.96% from -$1.6 million recorded in FY2022.
  • In the past 5 years, ADC Therapeutics' Deferred Taxes registered a high of $37.1 million during FY2023, and its lowest value of -$1.6 million during FY2022.
  • Over the past 3 years, ADC Therapeutics' median Deferred Taxes value was -$26,049 (recorded in 2021), while the average stood at $11.8 million.
  • As far as peak fluctuations go, ADC Therapeutics' Deferred Taxes slumped by 6,122.89% in 2022, and later skyrocketed by 2,388.96% in 2023.
  • Over the past 3 years, ADC Therapeutics' Deferred Taxes (Yearly) stood at -$26,049 in 2021, then tumbled by 6,122.89% to -$1.6 million in 2022, then spiked by 2,388.96% to $37.1 million in 2023.